Pages that link to "Q48482082"
Jump to navigation
Jump to search
The following pages link to Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure (Q48482082):
Displaying 50 items.
- Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis (Q28383719) (← links)
- Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. (Q30352821) (← links)
- Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis (Q31121727) (← links)
- Genome-wide association scan identifies variants near Matrix Metalloproteinase (MMP) genes on chromosome 11q21-22 strongly associated with serum MMP-1 levels (Q33572465) (← links)
- Membrane-associated matrix proteolysis and heart failure. (Q33632033) (← links)
- Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality (Q34222299) (← links)
- Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss (Q34328671) (← links)
- Circulating annexin A5 levels after atrial switch for transposition of the great arteries: relationship with ventricular deformation and geometry (Q34533063) (← links)
- Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota (Q36026805) (← links)
- Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum (Q36167458) (← links)
- Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population. (Q36222011) (← links)
- MMP-2 and sTNF-R1 Variability in Patients with Essential Hypertension: 1-Year Follow-Up Study. (Q36253578) (← links)
- ECM remodeling in hypertensive heart disease (Q36749281) (← links)
- Mechanisms of cardiac fibrosis in hypertension (Q36873139) (← links)
- Biochemical markers of myocardial remodelling in hypertensive heart disease (Q37258076) (← links)
- Fenofibrate inhibits aldosterone-induced apoptosis in adult rat ventricular myocytes via stress-activated kinase-dependent mechanisms (Q37276153) (← links)
- Hypertension and heart failure: a dysfunction of systole, diastole or both? (Q37335867) (← links)
- Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy. (Q37358560) (← links)
- Integrating the myocardial matrix into heart failure recognition and management (Q37406111) (← links)
- Extracellular matrix fibrotic markers in heart failure (Q37464914) (← links)
- Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and heart failure outcomes (Q37705626) (← links)
- The Progression of Hypertensive Heart Disease (Q37832070) (← links)
- Biomarkers of Myocardial Fibrosis (Q37855500) (← links)
- Role of various proteases in cardiac remodeling and progression of heart failure (Q37899085) (← links)
- Structural remodeling and mechanical function in heart failure (Q37977013) (← links)
- Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease (Q38061567) (← links)
- Myofibroblast-mediated mechanisms of pathological remodelling of the heart (Q38064729) (← links)
- Circulating biomarkers in patients with heart failure and preserved ejection fraction (Q38152289) (← links)
- Heart failure with preserved ejection fraction: a clinical dilemma (Q38195149) (← links)
- The role of cardiac biochemical markers in aortic stenosis. (Q38743657) (← links)
- Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. (Q38858284) (← links)
- Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure (Q39950053) (← links)
- A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats (Q39914658) (← links)
- DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats (Q42007460) (← links)
- KLF15 and cardiac fibrosis: the heart thickens (Q42019573) (← links)
- MicroRNA-19b is a potential biomarker of increased myocardial collagen cross-linking in patients with aortic stenosis and heart failure (Q42330259) (← links)
- Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution (Q43136508) (← links)
- Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix (Q46745968) (← links)
- Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study (Q47392248) (← links)
- Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. (Q47677252) (← links)
- Matrix metalloproteinase-1 and -2 levels are differently regulated in acute exacerbation of heart failure in patients with and without left ventricular systolic dysfunction (Q47732973) (← links)
- Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study (Q47960038) (← links)
- Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat (Q48365878) (← links)
- Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? (Q49106557) (← links)
- Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy (Q50501810) (← links)
- Vascular Endothelial Growth Factor Prevents Endothelial-to-Mesenchymal Transition in Hypertrophy (Q50663774) (← links)
- Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function (Q51458639) (← links)
- Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene. (Q52886857) (← links)
- Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis. (Q53113411) (← links)
- Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease. (Q53185348) (← links)